AACR Special Conference in Cancer Research: Expanding and Translating Cancer Synthetic Vulnerabilities
June 10-13, 2024
Doubletree by Hilton Montreal
Montreal, Quebec, Canada
Conference cochairs
Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts
E. Alejandro Sweet-Cordero, University of California, San Francisco, California
Michael Erb, The Scripps Research Institute, La Jolla, California
Kris C. Wood, Duke University School of Medicine, Durham, North Carolina
Join us at the forefront of cancer research as we delve into the captivating world of synthetic lethality. The conference promises to be an illuminating gathering of leading researchers, clinicians, industry and academia, all dedicated to unraveling the intricacies exploiting lethal genetic interactions and tumor-specific mutations to exploit synthetic vulnerabilities. Plenary sessions will cover a range of critical topics, including advances the latest techniques for identifying and targeting synthetic lethal interactions, use of large datasets to uncover hidden connections and patterns, a comprehensive overview of therapeutic avenues, and analysis of synthetic lethality in the context of residual disease to tackle treatment-resistant cancer.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
